Correction

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study (vol 12, pg 435, 2013)

LANCET NEUROLOGY (2013)

Volume 12, Issue 5, Pages 423-423

DOI: 10.1016/S1474-4422(13)70061-9

Click your name to claim this paper and add it to your profile.